Stephan Busque

Transplant surgeon, Kidney transplant surgeon, Pancreas transplant surgeon, Living donor nephrectomy surgeon

Professor of Surgery (Abdominal Transplantation) at the Stanford University Medical Center

Kidney and Pancreas Transplant Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-9891
Learn More About the Clinic Getting Here Make An Appointment

Liver Transplant Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-498-7878
Learn More About the Clinic Getting Here Make An Appointment

Liver Transplant Program at Boswell Building

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-498-7878
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: University of Montreal (1991) Canada

Medical Education: University of Montreal (1986) Canada

Fellowship: California Pacific Medical Center (1995) CA

Internship: University of Montreal (1987) Canada

Board Certification: General Surgery, American Board of Surgery (1996)

Board Cerification, American Board of Surgery, General Surgery (1996)

M. Sc., Mc Gill University, Transplant Immunology (1995)

., California Pacific Med Center, Multi-Organ Transplantation (1995)

FRCSC, University of Montreal, General Surgery (1991)

MD, Univerty of Montreal (1986)

Administrative Appointments

Director Adult Kidney and Pancreas Transplant Program, Stanford University School of Medicine (2001 - Present)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Uniform Long-Term Graft Survival in a Clincial Trial of the Induction of Tolerance to Kidney Transplants.
Scandling, J., Busque, S., Shori, A., Dejbakhsh-Jones, S., Shizuru, J., & Strober, S. (2013). Uniform Long-Term Graft Survival in a Clincial Trial of the Induction of Tolerance to Kidney Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 13, 200-200.

Evaluating Deceased Donor Registries: Identifying Predictive Factors of Donor Designation
Hajhosseini, B., Stewart, B., Tan, J. C., Busque, S., & Melcher, M. L. (2013). Evaluating Deceased Donor Registries: Identifying Predictive Factors of Donor Designation. AMERICAN SURGEON, 79(3), 235-241.

Desensitization Combined With Paired Exchange Leads to Successful Transplantation in Highly Sensitized Kidney Transplant Recipients: Strategy and Report of Five Cases
Yabu, J. M., Pando, M. J., Busque, S., & Melcher, M. L. (2013). Desensitization Combined With Paired Exchange Leads to Successful Transplantation in Highly Sensitized Kidney Transplant Recipients: Strategy and Report of Five Cases. TRANSPLANTATION PROCEEDINGS, 45(1), 82-87.

A preconditioning regimen with a PKC? activator improves islet graft function in a mouse transplant model.
Hamilton, D., Rugg, C., Davis, N., Kvezereli, M., Tafti, B. A., & Fontaine, M. (2013). A preconditioning regimen with a PKC? activator improves islet graft function in a mouse transplant model. Cell transplantation.

Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year
Vincenti, F., Silva, H. T., Busque, S., O'Connell, P., Friedewald, J., & Chan, G. (2012). Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year. AMERICAN JOURNAL OF TRANSPLANTATION, 12(9), 2446-2456.

Chain Transplantation: Initial Experience of a Large Multicenter Program
Melcher, M. L., Leeser, D. B., Gritsch, H. A., Milner, J., Kapur, S., & VEALE, J. L. (2012). Chain Transplantation: Initial Experience of a Large Multicenter Program. AMERICAN JOURNAL OF TRANSPLANTATION, 12(9), 2429-2436.

Incidental kidney stones: a single center experience with kidney donor selection
Kim, I. K., Tan, J. C., Lapasia, J., Elihu, A., Busque, S., & Melcher, M. L. (2012). Incidental kidney stones: a single center experience with kidney donor selection. CLINICAL TRANSPLANTATION, 26(4), 558-563.

Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Sarwal, M., & Strober, S. (2012). Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 12(5), 1133-1145.

Validity of Surrogate Measures for Functional Nephron Mass
Tan, J. C., Paik, J., Chertow, G. M., Grumet, F. C., Busque, S., & Desai, M. (2011). Validity of Surrogate Measures for Functional Nephron Mass. TRANSPLANTATION, 92(12), 1335-1341.

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation
Busque, S., Cantarovich, M., Mulgaonkar, S., Gaston, R., Gaber, A. O., & Meier-Kriesche, H.-U. (2011). The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 11(12), 2675-2684.

Induced Immune Tolerance for Kidney Transplantation
Scandling, J. D., Busque, S., Shizuru, J. A., Engleman, E. G., & Strober, S. (2011). Induced Immune Tolerance for Kidney Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 365(14), 1359-1360.

12-MONTH RESULTS OF TOFACITINIB (CP-690,550)-BASED CNI-FREE IMMUNOSUPPRESSION IN A PHASE 2B STUDY IN DE NOVO KIDNEY TRANSPLANT PATIENTS
Vincenti, F., Silva, H. T., Busque, S., O'Connell, P., Friedewald, J., & Chan, G. (2011). 12-MONTH RESULTS OF TOFACITINIB (CP-690,550)-BASED CNI-FREE IMMUNOSUPPRESSION IN A PHASE 2B STUDY IN DE NOVO KIDNEY TRANSPLANT PATIENTS. TRANSPLANT INTERNATIONAL, 24, 97-97.

Managing Finances of Shipping Living Donor Kidneys for Donor Exchanges
Mast, D. A., Vaughan, W., Busque, S., VEALE, J. L., Roberts, J. P., & Melcher, M. L. (2011). Managing Finances of Shipping Living Donor Kidneys for Donor Exchanges. AMERICAN JOURNAL OF TRANSPLANTATION, 11(9), 1810-1814.

Living donor evaluation and exclusion: the Stanford experience
Lapasia, J. B., Kong, S.- yee, Busque, S., Scandling, J. D., Chertow, G. M., & Tan, J. C. (2011). Living donor evaluation and exclusion: the Stanford experience. CLINICAL TRANSPLANTATION, 25(5), 697-704.

Changes in T Cell Subsets in 12 Patients Enrolled in a Tolerance Induction Protocol with Combined Kidney and Hematopoietic Cell Transplantation.
Dejbakhsh-Jones, S., Takahashi, K., Jensen, K. P., Busque, S., Scandling, J. D., & Strober, S. (2011). Changes in T Cell Subsets in 12 Patients Enrolled in a Tolerance Induction Protocol with Combined Kidney and Hematopoietic Cell Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 11, 177-177.

C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation
Yabu, J. M., Higgins, J. P., Chen, G., Sequeira, F., Busque, S., & Tyan, D. B. (2011). C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation. TRANSPLANTATION, 91(3), 342-347.

Debate: PRO Position Formal Assessment of Donor Kidney Function Should Be Mandatory
Tan, J. C., Busque, S., Ho, B., & Myers, B. D. (2011). Debate: PRO Position Formal Assessment of Donor Kidney Function Should Be Mandatory. AMERICAN JOURNAL OF NEPHROLOGY, 33(3), 198-200.

Population Pharmacokinetic Analysis of Mycophenolic Acid Coadministered With Either Tasocitinib (CP-690,550) or Tacrolimus in Adult Renal Allograft Recipients
Lamba, M., Tafti, B., Melcher, M., Chan, G., Krishnaswami, S., & Busque, S. (2010). Population Pharmacokinetic Analysis of Mycophenolic Acid Coadministered With Either Tasocitinib (CP-690,550) or Tacrolimus in Adult Renal Allograft Recipients. THERAPEUTIC DRUG MONITORING, 32(6), 778-781.

Effects of aging on glomerular function and number in living kidney donors
Tan, J. C., Busque, S., Workeneh, B., Ho, B., Derby, G., & Myers, B. D. (2010). Effects of aging on glomerular function and number in living kidney donors. KIDNEY INTERNATIONAL, 78(7), 686-692.

Imprecision of Creatinine-Based GFR Estimates in Uninephric Kidney Donors
Tan, J. C., Ho, B., Busque, S., Blouch, K., Derby, G., & Myers, B. D. (2010). Imprecision of Creatinine-Based GFR Estimates in Uninephric Kidney Donors. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(3), 497-502.

Gene Arrays May Predict Stable Clinical Kidney Tolerance and Support Safe Immunosuppression Withdrawal
Sarwal, M. M., Li, L., Hsieh, S.-C., Lowsky, R., Busque, S., & Strober, S. (2010). Gene Arrays May Predict Stable Clinical Kidney Tolerance and Support Safe Immunosuppression Withdrawal. AMERICAN JOURNAL OF TRANSPLANTATION, 10, 1-1.

Factors Associated With Progression of Interstitial Fibrosis in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil
Rush, D. N., Cockfield, S. M., Nickerson, P. W., Arlen, D. J., Boucher, A., & Yilmaz, S. (2009). Factors Associated With Progression of Interstitial Fibrosis in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil. TRANSPLANTATION, 88(7), 897-903.

Asynchronous, Out-of-Sequence, Transcontinental Chain Kidney Transplantation: A Novel Concept
Butt, F. K., Gritsch, H. A., Schulam, P., Danovitch, G. M., Wilkinson, A., & Veale, J. L. (2009). Asynchronous, Out-of-Sequence, Transcontinental Chain Kidney Transplantation: A Novel Concept. AMERICAN JOURNAL OF TRANSPLANTATION, 9(9), 2180-2185.

Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients
Busque, S., Leventhal, J., Brennan, D. C., Steinberg, S., Klintmalm, G., & Chan, G. (2009). Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9(8), 1936-1945.

Accounting for Donor Charges in Kidney Donor Chains.
Melcher, M. L., Veale, J., Mast, D., Standridge, K., Goldberg, S., & Busque, S. (2009). Accounting for Donor Charges in Kidney Donor Chains. AMERICAN JOURNAL OF TRANSPLANTATION, 9, 435-436.

Glomerular Function, Structure, and Number in Renal Allografts from Older Deceased Donors
Tan, J. C., Workeneh, B., Busque, S., Blouch, K., Derby, G., & Myers, B. D. (2009). Glomerular Function, Structure, and Number in Renal Allografts from Older Deceased Donors. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 20(1), 181-188.

Gene Arrays May Predict Stable Clinical Tolerance and Support Safe Immunosuppression Withdrawal.
Sarwal, M. M., Li, L., Hsieh, S.-C., Lowsky, R., Busque, S., & Strober, S. (2009). Gene Arrays May Predict Stable Clinical Tolerance and Support Safe Immunosuppression Withdrawal. AMERICAN JOURNAL OF TRANSPLANTATION, 9, 280-280.

Glomerular function and number in ECD transplants
Workeneh, B., Busque, S., Derby, G., Blouch, K., Myers, B., & Tan, J. (2008). Glomerular function and number in ECD transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 8, 602-602.

Islet cell survival during isolation improved through protein kinase C epsilon activation
Kvezereli, M., Vallentin, A., Mochly-Rosen, D., Busque, S., & Fontaine, M. J. (2008). Islet cell survival during isolation improved through protein kinase C epsilon activation. TRANSPLANTATION PROCEEDINGS, 40(2), 375-378.

Tolerance and chimerism after renal and hematopoietic-cell transplantation.
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., & Strober, S. (2008). Tolerance and chimerism after renal and hematopoietic-cell transplantation. New England journal of medicine, 358(4), 362-368.

Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study
Rush, D., Arlen, D., Boucher, A., Busque, S., Cockfield, S. M., & Yilmaz, S. (2007). Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study. AMERICAN JOURNAL OF TRANSPLANTATION, 7(11), 2538-2545.

Once-daily tacrolimus extended release formulation: Experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients
Florman, S., Alloway, R., Kalayoglu, M., Punch, J., Bak, T., & First, M. R. (2007). Once-daily tacrolimus extended release formulation: Experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. TRANSPLANTATION, 83(12), 1639-1642.

Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging
Sze, D. Y., Strobel, N., Fahrig, R., Moore, T., Busque, S., & Frisoli, J. K. (2006). Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 17(4), 711-715.

Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia
Greenstein, J., Guest, S., Tan, J. C., Tummala, P., Busque, S., & Rabkin, R. (2006). Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia. JOURNAL OF RENAL NUTRITION, 16(2), 141-149.

Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation
Ma, I. Wy., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D. C., & Scandling, J. D. (2006). Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. CLINICAL TRANSPLANTATION, 20(2), 139-146.

Treatment of hepatic venous outflow obstruction after piggyback liver transplantation
Wang, S. L., Sze, D. Y., Busque, S., Razavi, M. K., Kee, S. T., & Dake, M. D. (2005). Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. RADIOLOGY, 236(1), 352-359.

Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion
White, M., Haddad, H., Leblanc, M. H., Giannetti, N., Pflugfelder, P., & Ross, H. (2005). Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(7), 798-809.

Conversion of stable liver transplant recipients from a twice-daily prograf-based regimen to a once-daily modified release tacrolimus-based regimen
Florman, S., Alloway, R., Kalayoglu, M., Lake, K., Bak, T., & First, M. R. (2005). Conversion of stable liver transplant recipients from a twice-daily prograf-based regimen to a once-daily modified release tacrolimus-based regimen. TRANSPLANTATION PROCEEDINGS, 37(2), 1211-1213.

A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients
Zaltzman, J. S., Boucher, A., Busque, S., Halloran, P. F., Landsberg, D. N., & Ferguson, R. (2005). A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients. CLINICAL TRANSPLANTATION, 19(1), 26-32.

Preoperative renal volumes as a predictor of graft function in living donor transplantation
Saxena, A. B., Busque, S., Arjane, P., Myers, B. D., & Tan, J. C. (2004). Preoperative renal volumes as a predictor of graft function in living donor transplantation. AMERICAN JOURNAL OF KIDNEY DISEASES, 44(5), 877-885.

Effect of steroid avoidance on early graft function after kidney transplantation
Roozrokh, H. C., Chen, L., Scandling, J. D., Momsen, A., Tan, J., & Busque, S. (2004). Effect of steroid avoidance on early graft function after kidney transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 4, 354-354.

Pre-operative MRI kidney volumes as a predictor of graft function in living donor kidney transplantation.
Bhatt, A., Arjane, P., Busque, S., & Tan, J. C. (2003). Pre-operative MRI kidney volumes as a predictor of graft function in living donor kidney transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14, 11A-11A.

Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation
JOHNSON, S., Qi, S. J., Xu, D. S., Jolicoeur, M., Liu, D. Y., & Chen, H. F. (2003). Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation. MICROSURGERY, 23(5), 476-482.

Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: A single center experience
Beaunoyer, M., Busque, S., St-Louis, G., Smeesters, C., Paquet, M. P., & Daloze, P. (2002). Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: A single center experience. TRANSPLANTATION PROCEEDINGS, 34(5), 1694-1695.

Chest wall and liver resection for chondrosarcoma
Noiseux, N., Ferraro, P., Busque, S., Harris, P., & Duranceau, A. (2002). Chest wall and liver resection for chondrosarcoma. ANNALS OF THORACIC SURGERY, 74(2), 598-598.

In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil
Morissette, P., Albert, C., Busque, S., St-Louis, G., & Vinet, B. (2001). In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil. THERAPEUTIC DRUG MONITORING, 23(5), 520-525.

Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients
Zaltzman, J., McAlister, V., Russell, D., Halloran, P., Landsberg, D., & Peets, J. (2001). Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1044-1045.

Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation
Busque, S., Shoker, A., Landsberg, D., McAlister, V., Halloran, P., & Schulz, M. (2001). Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1266-1267.

Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation
Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Busque, S., & Esquivel, C. O. (1999). Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. ARCHIVES OF SURGERY, 134(1), 25-29.

[Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus].
Busque, S., Demers, P., Saint-Louis, G., Boily, J. G., Tousignant, J., & Daloze, P. (1999). [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus]. Annales de chirurgie, 53(8), 687-689.

Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat
Chen, H., Qi, S., Xu, D., Wu, J., Busque, S., & Daloze, P. (1998). Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat. TRANSPLANTATION PROCEEDINGS, 30(4), 1049-1050.

Conversion from neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis
Busque, S., Demers, P., St-Louis, G., Boily, J. G., Tousignant, J., & Daloze, P. (1998). Conversion from neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. TRANSPLANTATION PROCEEDINGS, 30(4), 1247-1248.

Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation
Busque, S., Esquivel, C. O., Concepcion, W., & So, S. Ks. (1998). Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. TRANSPLANTATION, 65(1), 77-82.

Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat
Vu, M. D., Qi, S. J., Xu, D. S., Wu, J. P., Fitzsimmons, W. E., & Chen, H. F. (1997). Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. TRANSPLANTATION, 64(12), 1853-1856.

Left hepaticogastrostomy for biliary obstruction: Long-term results
Soulez, G., Therasse, E., Oliva, V. L., Pomp, A., Busque, S., & Gagner, M. (1997). Left hepaticogastrostomy for biliary obstruction: Long-term results. RADIOLOGY, 204(3), 780-786.

Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats
Chen, H., Xu, D., Qi, S., Busque, S., Tan, A., & Daloze, P. (1997). Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats. TRANSPLANTATION PROCEEDINGS, 29(1-2), 697-698.

Intra-hepatic glutathione and oxidative stress in liver transplantation in the pig.
Yandza, T., Manika, A., Huynh, T., Lavoie, J. C., Champagne, J., & Proulx, F. (1997). Intra-hepatic glutathione and oxidative stress in liver transplantation in the pig. ANNALES DE CHIRURGIE, 51(8), 839-844.

Primary liver transplantation without transfusion of red blood cells
Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Chuljian, P., & Esquivel, C. O. (1996). Primary liver transplantation without transfusion of red blood cells. SURGERY, 120(4), 698-704.

CYCLOSPORINE AND THE REVERSIBILITY OF CHRONIC VASCULAR REJECTION
Guttmann, R. D., Forbes, R. Dc., Zheng, S., & Busque, S. (1994). CYCLOSPORINE AND THE REVERSIBILITY OF CHRONIC VASCULAR REJECTION. TRANSPLANTATION PROCEEDINGS, 26(5), 2564-2566.

PASSENGER LEUKOCYTE EFFECT NOT MEDIATED BY INTERSTITIAL DENDRITIC CELLS
Guttmann, R. D., Forbes, R. Dc., Busque, S., Zheng, S., ALSAFFAR, M., & Colle, E. (1993). PASSENGER LEUKOCYTE EFFECT NOT MEDIATED BY INTERSTITIAL DENDRITIC CELLS. TRANSPLANTATION PROCEEDINGS, 25(1), 98-98.

SIMULTANEOUS LIVER AND WHOLE PANCREAS HARVESTING IN THE MULTIORGAN CADAVERIC DONOR
Corman, J., Daloze, P., Smeesters, C., Aboujaoude, M., Busque, S., & Beauregard, H. (1990). SIMULTANEOUS LIVER AND WHOLE PANCREAS HARVESTING IN THE MULTIORGAN CADAVERIC DONOR. CANADIAN JOURNAL OF SURGERY, 33(4), 277-281.